Precision Lung Cancer Survivorship Care Intervention
Recruiting · NCT05857995 · Interventional (participants receive a specific treatment) · Lead sponsor: Jerod L Stapleton, PhD
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Who can take part
Inclusion criteria
- Have been diagnosed with lung cancer
- Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
- Be at least 18 years of age or older
- Be able to communicate effectively in English
Exclusion criteria
- Have significant psychiatric disturbance that requires a higher level of care
- Have substance abuse/dependence that requires a higher level of care
- Are participating in another lung cancer survivorship care intervention
- Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program
Where it is running
1 location listed across 1 US state.
- Markey Cancer Center - Lexington, Kentucky, United States